Ardsley Advisory Partners LP Edwards Lifesciences Corp Transaction History

Ardsley Advisory Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $179,225 - $228,075	-2,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $167,975 - $218,600	2,500 New	2,500 $200,000
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $145,160 - $155,320	-4,000 Closed	0 $0
Q2 2017 Sep 21, 2017	BUY	N/A	4,000	4,000 $473,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.